202 related articles for article (PubMed ID: 1330634)
21. Phosphorylation of inositol 1,4,5-trisphosphate analogues by 3-kinase and dephosphorylation of inositol 1,3,4,5-tetrakisphosphate analogues by 5-phosphatase.
Van Dijken P; Lammers AA; Ozaki S; Potter BV; Erneux C; Van Haastert PJ
Eur J Biochem; 1994 Dec; 226(2):561-6. PubMed ID: 8001571
[TBL] [Abstract][Full Text] [Related]
22. Use of phosphorofluoridate analogues of D-myo-inositol 1,4,5-trisphosphate to assess the involvement of ionic interactions in its recognition by the receptor and metabolising enzymes.
Yoshimura K; Watanabe Y; Erneux C; Hirata M
Cell Signal; 1999 Feb; 11(2):117-25. PubMed ID: 10048789
[TBL] [Abstract][Full Text] [Related]
23. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and application of photoaffinity analogues of inositol 1,4,5-trisphosphate selectively substituted at the 1-phosphate group.
Schäfer R; Nehls-Sahabandu M; Grabowsky B; Dehlinger-Kremer M; Schulz I; Mayr GW
Biochem J; 1990 Dec; 272(3):817-25. PubMed ID: 2176480
[TBL] [Abstract][Full Text] [Related]
25. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors.
Murphy CT; Riley AM; Lindley CJ; Jenkins DJ; Westwick J; Potter BV
Mol Pharmacol; 1997 Oct; 52(4):741-8. PubMed ID: 9380038
[TBL] [Abstract][Full Text] [Related]
26. Binding and activity of the nine possible regioisomers of myo-inositol tetrakisphosphate at the inositol 1,4,5-trisphosphate receptor.
Burford NT; Nahorski SR; Chung SK; Chang YT; Wilcox RA
Cell Calcium; 1997 Apr; 21(4):301-10. PubMed ID: 9160166
[TBL] [Abstract][Full Text] [Related]
27. D-myo-inositol 1,4,5-trisphosphate analogues modified at the 3-position inhibit phosphatidylinositol 3-kinase.
Ward SG; Mills SJ; Liu C; Westwick J; Potter BV
J Biol Chem; 1995 May; 270(20):12075-84. PubMed ID: 7744856
[TBL] [Abstract][Full Text] [Related]
28. Calcium-sensitivity of inositol 1,4,5-trisphosphate metabolism in exocrine cells from the avian salt gland.
Hildebrandt JP; Shuttleworth TJ
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):703-10. PubMed ID: 1313230
[TBL] [Abstract][Full Text] [Related]
29. A comparison between muscarinic receptor occupancy, inositol 1,4,5-trisphosphate accumulation and Ca2+ mobilization in permeabilized SH-SY5Y neuroblastoma cells.
Safrany ST; Nahorski SR
Neuropharmacology; 1994 Jul; 33(7):837-46. PubMed ID: 7969802
[TBL] [Abstract][Full Text] [Related]
30. Catalytic properties of inositol trisphosphate kinase: activation by Ca2+ and calmodulin.
Ryu SH; Lee SY; Lee KY; Rhee SG
FASEB J; 1987 Nov; 1(5):388-93. PubMed ID: 2824270
[TBL] [Abstract][Full Text] [Related]
31. Ca2+/calmodulin-sensitive inositol 1,4,5-trisphosphate 3-kinase in rat and bovine brain tissues.
Takazawa K; Passareiro H; Dumont JE; Erneux C
Biochem Biophys Res Commun; 1988 Jun; 153(2):632-41. PubMed ID: 2838022
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of inositol 1,4,5-trisphosphate metabolism in permeabilised SH-SY5Y human neuroblastoma cells by a phosphorothioate-containing analogue of inositol 1,4,5-trisphosphate.
Wojcikiewicz RJ; Cooke AM; Potter BV; Nahorski SR
Eur J Biochem; 1990 Sep; 192(2):459-67. PubMed ID: 2209601
[TBL] [Abstract][Full Text] [Related]
33. Inositol 1,3,4,5-tetrakisphosphate-induced release of intracellular Ca2+ in SH-SY5Y neuroblastoma cells.
Gawler DJ; Potter BV; Nahorski SR
Biochem J; 1990 Dec; 272(2):519-24. PubMed ID: 2176465
[TBL] [Abstract][Full Text] [Related]
34. Inositol 1,4,5-trisphosphate receptor subtypes differentially recognize regioisomers of D-myo-inositol 1,4,5-trisphosphate.
Hirata M; Takeuchi H; Riley AM; Mills SJ; Watanabe Y; Potter BV
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):93-8. PubMed ID: 9359838
[TBL] [Abstract][Full Text] [Related]
35. Interaction of benzene 1,2,4-trisphosphate with inositol 1,4,5-trisphosphate receptor and metabolizing enzymes.
Poitras M; Bernier S; Boulay G; Fournier A; Guillemette G
Eur J Pharmacol; 1993 Feb; 244(3):203-10. PubMed ID: 8384566
[TBL] [Abstract][Full Text] [Related]
36. The perturbation, by aluminium, of receptor-generated calcium transients in hepatocytes is not due to effects of Ins(1,4,5)P3-stimulated Ca2+ release or Ins(1,4,5)P3 metabolism by the 5-phosphatase and 3-kinase.
Shears SB; Dawson AP; Loomis-Husselbee JW; Cullen PJ
Biochem J; 1990 Sep; 270(3):837. PubMed ID: 2173553
[No Abstract] [Full Text] [Related]
37. Dephosphorylation of myo-inositol 1,4,5-trisphosphate and myo-inositol 1,3,4-triphosphate.
Shears SB; Storey DJ; Morris AJ; Cubitt AB; Parry JB; Michell RH; Kirk CJ
Biochem J; 1987 Mar; 242(2):393-402. PubMed ID: 3036088
[TBL] [Abstract][Full Text] [Related]
38. Characterisation of stereospecific binding sites for inositol 1,4,5-trisphosphate in airway smooth muscle.
Chilvers ER; Challiss RA; Willcocks AL; Potter BV; Barnes PJ; Nahorski SR
Br J Pharmacol; 1990 Feb; 99(2):297-302. PubMed ID: 2158373
[TBL] [Abstract][Full Text] [Related]
39. Ca2+ regulates the inositol tris/tetrakisphosphate pathway in intact and broken preparations of insulin-secreting RINm5F cells.
Biden TJ; Wollheim CB
J Biol Chem; 1986 Sep; 261(26):11931-4. PubMed ID: 3017952
[TBL] [Abstract][Full Text] [Related]
40. 1D-myo-inositol 1,4,5-trisphosphate dephosphorylation by rat enterocytes involves an intracellular 5-phosphatase and non-specific phosphatase activity at the cell surface.
Rubiera C; Velasco G; Michell RH; Lazo PS; Shears SB
Biochem J; 1988 Oct; 255(1):131-7. PubMed ID: 2848503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]